Skip to main content

Press Releases Archive

Press Releases

Follow us on our mission to revolutionize cancer medicine

Series B Financing

09th July 2019

BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Ind…

BioNTech and Genmab

17th June 2019

BioNTech and Genmab Initiate First-In-Human Phase I/IIa Trial of Bispecific Antibody Du…

BioNTech Acquires MabVax

08th May 2019

BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio

Ugur-Sahin

28th February 2019

BioNTech Congratulates CEO and Co-founder Prof. Ugur Sahin on German Cancer Award 2019…

MAB Discovery

23rd January 2019

BioNTech to Acquire Antibody Generation Unit of MAB Discovery

Transition from AG to SE

04th January 2019

BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as…

Sanofi Invests

04th January 2019

Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration…

BioNTech and the University of Pennsylvania

05th November 2018

BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration…

BioNTech Signs Collaboration Agreement with Pfizer

16th August 2018

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for P…

BioNTech and SMP

01st August 2018

BioNTech and SMP to evaluate SMP’s next generation technology for BioNTech products…

BioNTech and Genevant Sciences

10th June 2018

BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases

Dr. Özlem Türeci

29th May 2018

BioNTech Appoints Dr. Özlem Türeci as Chief Medical Officer

JPT Peptide Technologies

11th April 2018

JPT Peptide Technologies launches The Human Proteome Peptide Catalog

BioNTech Secures USD 270 Million

04th January 2018

BioNTech Secures USD 270 Million in Series A Financing

BioNTech to Present

21st December 2017

BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference

BioNTech Honored as WuXi AppTec Biotech Company

30th November 2017

BioNTech Honored as WuXi AppTec Biotech Company of the Year at Scrip Awards 2017

BioNTech Manufacturing Subsidiar

01st October 2017

BioNTech Manufacturing Subsidiary, EUFETS, Becomes BioNTech Innovative Manufacturing Servi…

BioNTech AG to Present

19th September 2017

BioNTech AG to Present at Cantor Fitzgerald Healthcare Conference

BioNTech AG Enters

06th September 2017

BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Developmen…

Announcement_BioNTech Diagnostics GmbH

09th August 2017

Announcement: BioNTech Diagnostics GmbH and Metropolis Healthcare Ltd. announce partnershi…

Nature Publication Reports Favorable Clinical Trial Results

01st July 2017

Nature Publication Reports Favorable Clinical Trial Results of BioNTech’s Individualized C…

Nature Medicine Reports

12th June 2017

Nature Medicine Reports Elimination of large Tumors in Mice by mRNA-encoded Bispecific Ant…

BioNTech announces positive results

15th May 2017

BioNTech announces positive results of an international reproducibility study with MammaTy…

EU-funded consortium led by BioNTech

24th March 2017

EU-funded consortium led by BioNTech and Immatics announces completion of regular study tr…

BioNTech to present interim Phase

07th March 2017

BioNTech to present interim Phase I/II date for mRNA vaccine at AACR

BioNTech Presentation

22nd February 2017

BioNTech to Present at Cowen and Company’s 37th Annual Health Care Conference

MammaTyper enables more precise prediction

15th February 2017

MammaTyper® enables more precise prediction of the response to neoadjuvent chemotherapy co…

BioNTech to Present at JP Morgan 2017

22nd December 2016

BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017

Parker Institute for Cancer Immunotherapy

01st December 2016

Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaborati…

BioNTech to enter into worldwide

21st September 2016

BioNTech to enter into worldwide strategic collaboration with Genentech to develop individ…

Chinese FDA Grants MammaTyper

19th August 2016

Chinese FDA Grants MammaTyper® Innovative Product Status for Expedited Approval

Study confirms analytical precision of MammaTyper

12th July 2016

Study confirms analytical precision of MammaTyper® in molecular breast cancer typing

Study confirms advantages of the test kit MammaTyper

16th June 2016

Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohisto…

BioNTech Receives Emerging Star

14th June 2016

BioNTech Receives Emerging Star of the Year Award at the European Mediscience Awards

Nature publication describes first example

01st June 2016

Nature publication describes first example of a clinically applicable and systemic mRNA ca…

Bayer-and-BioNTech-develop-mRNA-Vaccines-for-Animal-Health-Applications

10th May 2016

Bayer and BioNTech Join Forces to Develop Innovative New mRNA Vaccines and Therapeutics fo…

BioNTech acquires operations 4SC Discovery division

29th April 2016

BioNTech acquires operations of 4SC Discovery division

BioNTech-Announces-collaboration-with-Genmab

11th January 2016

BioNTech Announces Update in Immuno-oncology Collaboration with Genmab

BioNTech present at JP Morgan 2016

15th December 2015

BioNTech to attend and present at 34th Annual JP Morgan Healthcare conference 2016

BioNTech and Shuwen announce partnership with MammaTyper

12th December 2015

BioNTech and Shuwen announce partnership to commercialize MammaTyper® in China

Communiqué-de-Presse-BioNTech-Sanofi-Coopération.pdf

11th November 2015

Sanofi and BioNTech Announce Cancer Immunotherapy Collaboration and License Agreement

HIV-scientists-develop-vaccine

02nd November 2015

HIV scientists launch 23 million euro project to develop vaccine

Cancer Research Consortium

29th June 2015

Cancer Research Consortium “IMMUNO-TRANSPORTER” funded by Federal Ministry of Education an…

Siemens and BioNTech cooperate

24th June 2015

Siemens and BioNTech cooperate on production of personalized cancer vaccines

BioNTech launches MammaTyper

10th June 2015

BioNTech launches MammaTyper® Breast Cancer Diagnostic

NATURE Publication

22nd May 2015

NATURE Publication: Breakthrough Development in Cancer Immunology

BioNTech and Genmab sign co-development

18th May 2015

BioNTech and Genmab sign co-development and commercialization agreement in immuno-oncology

Eli Lilly and BioNTech announce

11th May 2015

Eli Lilly and BioNTech announce Research Collaboration

EU-funded consortium led by immatics

15th October 2014

EU-funded consortium led by immatics and BioNTech to advance a novel class of fully person…

BioNTech AG and Ganymed Pharmaceuticals Open Research Headquarters

01st October 2014

BioNTech AG and Ganymed Pharmaceuticals AG Open New Research Headquarters in Mainz, German…

Sierk Poetting new CFO of BioNTech

01st September 2014

Sierk Poetting to be the new CFO of BioNTech Group

Prof. Dr. Katalin Karikó joins

02nd February 2014

Prof. Dr. Katalin Karikó joins BioNTech Group

Initiation of IVAC clinical trial

02nd February 2014

Initiation of IVAC clinical trial

We look forward to connecting with you